268 related articles for article (PubMed ID: 10331417)
1. Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy.
Fernández-Real JM; Molina A; Broch M; Ricart W; Gutiérrez C; Casamitjana R; Vendrell J; Soler J; Gómez-Sáez JM
Diabetes; 1999 May; 48(5):1108-12. PubMed ID: 10331417
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance.
Fernández-Real JM; Broch M; Ricart W; Casamitjana R; Gutierrez C; Vendrell J; Richart C
Diabetes; 1998 Nov; 47(11):1757-62. PubMed ID: 9792545
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of the soluble fraction of tumor necrosis factor receptors 1 and 2 are independent determinants of plasma cholesterol and LDL-cholesterol concentrations in healthy subjects.
Fernández-Real JM; Gutiérrez C; Ricart W; Castiñeira MJ; Vendrell J; Richart C
Atherosclerosis; 1999 Oct; 146(2):321-7. PubMed ID: 10532687
[TBL] [Abstract][Full Text] [Related]
4. Serum corticosteroid-binding globulin concentration and insulin resistance syndrome: a population study.
Fernandez-Real JM; Pugeat M; Grasa M; Broch M; Vendrell J; Brun J; Ricart W
J Clin Endocrinol Metab; 2002 Oct; 87(10):4686-90. PubMed ID: 12364459
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of soluble tumor necrosis factor-alpha receptor 2 are linked to insulin resistance and glucose intolerance in children.
Gupta A; Ten S; Anhalt H
J Pediatr Endocrinol Metab; 2005 Jan; 18(1):75-82. PubMed ID: 15679072
[TBL] [Abstract][Full Text] [Related]
6. Smoking, fat mass and activation of the tumor necrosis factor-alpha pathway.
Fernandez-Real JM; Broch M; Vendrell J; Ricart W
Int J Obes Relat Metab Disord; 2003 Dec; 27(12):1552-6. PubMed ID: 12975637
[TBL] [Abstract][Full Text] [Related]
7. Soluble tumor necrosis factor-alpha receptors in young obese subjects with normal and impaired glucose tolerance.
Dzienis-Straczkowska S; Straczkowski M; Szelachowska M; Stepien A; Kowalska I; Kinalska I
Diabetes Care; 2003 Mar; 26(3):875-80. PubMed ID: 12610052
[TBL] [Abstract][Full Text] [Related]
8. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women.
Fernandez-Real JM; Vayreda M; Richart C; Gutierrez C; Broch M; Vendrell J; Ricart W
J Clin Endocrinol Metab; 2001 Mar; 86(3):1154-9. PubMed ID: 11238501
[TBL] [Abstract][Full Text] [Related]
9. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus.
Svenungsson E; Gunnarsson I; Fei GZ; Lundberg IE; Klareskog L; Frostegård J
Arthritis Rheum; 2003 Sep; 48(9):2533-40. PubMed ID: 13130473
[TBL] [Abstract][Full Text] [Related]
10. Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-alpha system.
Straczkowski M; Dzienis-Straczkowska S; Stêpieñ A; Kowalska I; Szelachowska M; Kinalska I
J Clin Endocrinol Metab; 2002 Oct; 87(10):4602-6. PubMed ID: 12364441
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of soluble tumor necrosis factor-alpha receptors are related to total and LDL-cholesterol in lean, but not in obese subjects.
Straczkowski M; Kowalska I; Nikolajuk A; Adamska A; Karolczuk-Zarachowicz M; Karczewska-Kupczewska M; Kozlowska A; Gorska M
Cardiovasc Diabetol; 2006 Jun; 5():14. PubMed ID: 16803616
[TBL] [Abstract][Full Text] [Related]
12. Insulin regulation of leptin synthesis and secretion in humans: the model of myotonic dystrophy.
Gómez JM; Molina A; Fernández-Castañer M; Casamitjana R; Martínez-Matos JA; Soler J
Clin Endocrinol (Oxf); 1999 May; 50(5):569-75. PubMed ID: 10468921
[TBL] [Abstract][Full Text] [Related]
13. Increased plasma-soluble tumor necrosis factor-alpha receptor 2 level in lean nondiabetic offspring of type 2 diabetic subjects.
Straczkowski M; Kowalska I; Stepien A; Dzienis-Straczkowska S; Szelachowska M; Kinalska I
Diabetes Care; 2002 Oct; 25(10):1824-8. PubMed ID: 12351485
[TBL] [Abstract][Full Text] [Related]
14. Contribution of abnormal insulin secretion and insulin resistance to the pathogenesis of type 2 diabetes in myotonic dystrophy.
Perseghin G; Caumo A; Arcelloni C; Benedini S; Lanzi R; Pagliato E; Sereni LP; Testolin G; Battezzati A; Comi G; Comola M; Luzi L
Diabetes Care; 2003 Jul; 26(7):2112-8. PubMed ID: 12832322
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of insulin action and tumor necrosis factor alpha system activity by metformin.
Biarnés J; Fernández-Real JM; Fernández-Castañer M; del Mar García M; Soler J; Ricart W
Metabolism; 2005 Feb; 54(2):235-9. PubMed ID: 15690319
[TBL] [Abstract][Full Text] [Related]
16. Novel interactions of adiponectin with the endocrine system and inflammatory parameters.
Fernández-Real JM; López-Bermejo A; Casamitjana R; Ricart W
J Clin Endocrinol Metab; 2003 Jun; 88(6):2714-8. PubMed ID: 12788878
[TBL] [Abstract][Full Text] [Related]
17. Plasma soluble tumour necrosis factor-alpha receptor 2 is elevated in obesity: specific contribution of visceral adiposity.
Cartier A; Côté M; Bergeron J; Alméras N; Tremblay A; Lemieux I; Després JP
Clin Endocrinol (Oxf); 2010 Mar; 72(3):349-57. PubMed ID: 19650780
[TBL] [Abstract][Full Text] [Related]
18. The insulin resistance syndrome and the binding capacity of cortisol binding globulin (CBG) in men and women.
Fernández-Real JM; Grasa M; Casamitjana R; Ricart W
Clin Endocrinol (Oxf); 2000 Jan; 52(1):93-9. PubMed ID: 10651759
[TBL] [Abstract][Full Text] [Related]
19. Plasma adiponectin concentration and tumor necrosis factor-alpha system activity in lean non-diabetic offspring of type 2 diabetic subjects.
Kowalska I; Straczkowski M; Nikołajuk A; Krukowska A; Kinalska I; Górska M
Eur J Endocrinol; 2006 Feb; 154(2):319-24. PubMed ID: 16452547
[TBL] [Abstract][Full Text] [Related]
20. Relationship between plasma leptin levels and the tumor necrosis factor-alpha system in obese subjects.
Corica F; Allegra A; Corsonello A; Buemi M; Calapai G; Ruello A; Nicita Mauro V; Ceruso D
Int J Obes Relat Metab Disord; 1999 Apr; 23(4):355-60. PubMed ID: 10340812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]